Search results for "Medulla"

showing 4 items of 164 documents

Early auditory evoked potentials: developmental aspects and validity in neuropaediatric and audiologic disorders.

1984

Auditory evoked potentials and in this context especially five waves in the first 10 ms (early auditory evoked potentials = EAEP) are a diagnostic aid in topodiagnosis of posterior fossa diseases. This is due to waves I to V which arise along the acoustic nerve and in brain stem structures such as medulla, pons and mid-brain. Besides an indication about the site of a lesion in the posterior fossa, wave V allows an objective threshold determination. The present results were gained in normal children aged 1-3 years and in children with neuropaediatric and audiologic disorders.

Adultmedicine.medical_specialtyAgingAdolescentPosterior fossaNeural ConductionContext (language use)AudiologyDiagnostic aidLesionChild DevelopmentMedicineHumansChildHearing DisordersMedullaNeural Conductionbusiness.industryBrain NeoplasmsInfant NewbornInfantDiffuse Cerebral Sclerosis of SchilderLeukodystrophy MetachromaticPonsChild PreschoolPediatrics Perinatology and Child HealthNormal childrenEvoked Potentials Auditorymedicine.symptomNervous System DiseasesbusinessBrain StemEuropean journal of pediatrics
researchProduct

Experimentelle Bestimmung der Gleitreibungskräfte beim Einschlagen von Oberschenkelmarknägeln

1990

No data have published concerning the procedure of driving in intramedullary nails. An extensive experimental device consisting of a contact-free distance measurement, a dynamograph connected to strain gages and an accelerometer now enabled this investigation. Among other things we determined the range of sliding friction for each stroke at different levels of nail-progression. Depending of the depth of nail-progression forces between 200 N und 400 N were measured. When the nail is stuck these values rise to over 1000 N. The sliding-process lasted between 10 ms and 20 ms. Knowledge of these data is of major importance for improvement of surgical technique and possible development of mechani…

integumentary systembusiness.industryAccelerometerlaw.inventionIntramedullary rodStress (mechanics)Distance measurementlawFracture fixationNail (fastener)MedicineSurgeryskin and connective tissue diseasesbusinessStrain gaugeBiomedical engineeringUnfallchirurgie
researchProduct

Endogenous opioid peptide responses to opioid and anti-inflammatory medications following eccentric exercise-induced muscle damage.

2009

To determine the effects of Vicoprofen, Ibuprofen, and a placebo on the responses of endogenous opioid peptides following eccentric exercise-induced muscle damage 36 healthy men (age: 22.8 years; height: 178.8+/-6.2cm; body mass: 78.9+/-13.7kg; body fat: 15.8+/-6.5%) volunteered to participate in the study. Each participant was evaluated for pain 24h post and randomly assigned to an experimental group: VIC (Vicoprofen), IBU (Ibuprofen), or P (placebo). Medication was given four times daily (i.e., VIC (hydrocodone bitartrate 7.5mg with Ibuprofen 200mg) and IBU 200mg). Blood was obtained at rest and at 0, 24, 48, 72, 96 and 120h following the eccentric exercise damage protocol. No significant…

AdultMalemedicine.medical_specialtyAdolescentPhysiologyPhysical ExertionAnti-Inflammatory AgentsPainPhysical exercisePlaceboBiochemistryPlacebosCellular and Molecular NeuroscienceYoung AdultEndocrinologyDouble-Blind MethodInternal medicinemedicineEccentricAnimalsHumansOpioid peptideMuscle SkeletalExerciseEndogenous opioidPain MeasurementChemistryIbuprofenMagnetic Resonance ImagingEndocrinologymedicine.anatomical_structureOpioidOpioid PeptidesAdrenal medullamedicine.drugPeptides
researchProduct

“Weekly docetaxel and gemcitabine as first line treatment for metastatic breast cancer: results of a multicenter phase II study”

2004

<i>Objectives:</i> We conducted a multicenter phase II study to evaluate the clinical efficacy, toxicity, and dose intensity of a new weekly schedule of docetaxel and gemcitabine as first-line treatment of metastatic breast cancer patients. <i>Methods:</i> We enrolled 58 patients, 52% of whom had received a previous anthracycline-containing chemotherapy. The treatment schedule was: docetaxel 35 mg/m<sup>2</sup> and gemcitabine 800 mg/m<sup>2</sup> i.v. on days 1, 8, 15 every 28 days. <i>Results:</i> All patients were assessable for toxicity and 56 for efficacy. Overall response rate was 64.3% with 16.1% of complete responses and 48…

OncologyAdultCancer Researchmedicine.medical_specialtyMaximum Tolerated Dosemedicine.drug_classPhases of clinical researchBreast NeoplasmsDocetaxelAntimetaboliteDeoxycytidineMetastasisBreast cancerInternal medicineAntineoplastic Combined Chemotherapy ProtocolsMedicineHumansAgedNeoplasm Stagingbusiness.industryCarcinoma Ductal BreastGeneral MedicineMiddle Agedmedicine.diseaseMetastatic breast cancerGemcitabineGemcitabineSurgerySurvival RateCarcinoma LobularTreatment OutcomeOncologyDocetaxelCarcinoma MedullaryToxicityFemaleTaxoidsbusinessmedicine.drug
researchProduct